| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |